|
⚲
|
| Keyboard |
| TCG Crossover Management LLC
✚
|
|
|---|---|
| CRD # | 311718 |
| SEC # | 801-120001 |
| CIK # | 0001839948 |
| AUM | 5,055.3 M (2026-05-29) |
| Employees | 16 (56% Investors, 0% Brokers) |
| Phone | 650-924-9424 |
| Address | 245 Lytton Ave Palo Alto, CA 94301 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Abivax Sa | 0.7 | ||
| CG Oncology Inc | 0.2 | ||
| BCTG Acquisition Corp | 0.2 | ||
| UNUM Therapeutics Inc | 0.2 | ||
| Magenta Therapeutics Inc | 0.1 | ||
| TYRA Biosciences Inc | 0.1 | ||
| Health Sciences Acquisitions Corp | 0.1 | ||
| Biocryst Pharmaceuticals Inc | 0.1 | ||
| Mirum Pharmaceuticals Inc | 0.1 | ||
| Vor Biopharma Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | TCG Crossover Fund III LP | [2026-03-31] | 167.7 M | |
| Offered $1,200,000,000 · Filed 2025-06-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $1,200,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| Other | TCG Crossover Fund II LP | [2024-03-27] | 1,713.9 M | |
| Offered $900,000,000 · Filed 2023-04-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $900,000,000 · Duration One year or less · Revenue Not Applicable | ||||
| Other | TCG Crossover Fund I LP | [2021-03-30] | 800.0 M | 1,914.1 M |
| Offered $800,000,000 · Filed 2021-04-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Not Applicable | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 5.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 5.1 |
| By Discretionary | ||
| Discretionary | 3 | 5.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 5.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 5.1 | |
| Total | 3 | 5.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Chen Yu | Executive Officer | 24 | 3 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001839948] | |
| SC 13G | [0001839948] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Comparable Firms | State | AUM |
|---|---|---|
|
Alumina Investment Management LLC
✚
|
NC | 5,262.4 M |
|
Profund Advisors LLC
✚
|
MD | 5,200.0 M |
|
Altamar Partners North America LLC
✚
|
NY | 5,146.9 M |
|
Metropolis Capital Limited
✚
|
5,065.3 M | |
|
Healthcare Community Securities Corporation
✚
|
NY | 5,057.9 M |
|
20 Gates Management LLC
✚
|
NY | 4,966.9 M |
|
MC Credit Partners LP
✚
|
CT | 4,941.7 M |
|
Neuberger Berman Loan Advisers LLC
✚
|
IL | 4,928.0 M |
|
AGF Investments LLC
✚
|
MA | 4,921.9 M |
|
Swiss RE Insurance-Linked Investment Advisors Corporation
✚
|
NY | 4,907.7 M |